DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice.
about
Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcerToxoplasma rhoptries: unique secretory organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosisLong-term protective immune response elicited by vaccination with an expression genomic library of Toxoplasma gondii.Differential regulation of effector- and central-memory responses to Toxoplasma gondii Infection by IL-12 revealed by tracking of Tgd057-specific CD8+ T cells.Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment.Strain- and Dose-Dependent Reduction of Toxoplasma gondii Burden in Pigs Is Associated with Interferon-Gamma Production by CD8+ Lymphocytes in a Heterologous Challenge Model.Cellular immune responses to recombinant antigens in pregnant women chronically infected with Toxoplasma gondii.Analyzing and identifying novel B cell epitopes within Toxoplasma gondii GRA4.Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice.CpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB/c miceA GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infectionExpression and immunogenicity of Mycoplasma hyopneumoniae heat shock protein antigen P42 by DNA vaccinationParasite distribution and associated immune response during the acute phase of Toxoplasma gondii infection in sheepAlpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii.Evaluation of Pichia pastoris-expressed recombinant rhoptry protein 2 of Toxoplasma gondii for its application in diagnosis of toxoplasmosis.Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosisDNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB/c mice.Induction of protective immune responses by a multiantigenic DNA vaccine encoding GRA7 and ROP1 of Toxoplasma gondii.Immune responses induced by replication-defective adenovirus expressing the C-terminal portion of the Mycoplasma hyopneumoniae P97 adhesin.In vitro induction of Neospora caninum bradyzoites in vero cells reveals differential antigen expression, localization, and host-cell recognition of tachyzoites and bradyzoites.Molecular cloning and characterization of a matrix metalloproteinase, from Caenorhabditis elegans: employed to identify homologous protein from Angiostrongylus cantonensis.The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosisTransgenic Eimeria tenella as a vaccine vehicle: expressing TgSAG1 elicits protective immunity against Toxoplasma gondii infections in chickens and mice.Protective effect of DNA-mediated immunization with liposome-encapsulated GRA4 against infection of Toxoplasma gondiiVaccination concepts against Toxoplasma gondii.Vaccines against Toxoplasma gondii: challenges and opportunities.Current status of toxoplasmosis vaccine development.Induction of Protective Immunity against Toxoplasma gondii in Mice by Nucleoside Triphosphate Hydrolase-II (NTPase-II) Self-amplifying RNA Vaccine Encapsulated in Lipid Nanoparticle (LNP).Complex immune cell interplay in the gamma interferon response during Toxoplasma gondii infectionrROP2 from Toxoplasma gondii as a potential vaccine against oocyst shedding in domestic cats.The protective effect of a DNA vaccine encoding the Toxoplasma gondii cyclophilin gene in BALB/c mice.Immunization of C57BL/6 Mice with GRA2 Combined with MPL Conferred Partial Immune Protection against Toxoplasma gondiiImmunization with excreted-secreted antigens reduces tissue cyst formation in pigs.Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins.Characterisation of full-length cDNA sequences provides insights into the Eimeria tenella transcriptome.Construction and identification of Complex DNA vaccine of hepatitis B and Toxoplasma gondiiProtective immunity induced by a DNA vaccine-encoding Toxoplasma gondii microneme protein 11 against acute toxoplasmosis in BALB/c mice.Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: anti-Toxoplasma immune response in mice.Heterogeneity in cellular and humoral immune responses against Toxoplasma gondii antigen in humans.Protective effects of immunization with a recombinant cyst antigen in mouse models of infection with Toxoplasma gondii tissue cysts.
P2860
Q24548647-D7E6275F-8D81-434F-9720-1A453DB9D805Q28757592-B8A8873C-4064-4EE4-88FA-A4A9F483B5C8Q30786522-368CE50E-8B49-4C42-8561-D8D012D8B356Q33545222-B4A040E9-A3AC-4758-B4B9-22BB5564E817Q33595922-6190C6A5-A1BB-4641-8D22-EE163A0E690EQ33774912-42D24B39-1662-469F-9B76-D53978FD8C60Q33943411-8F54AD8C-FA2A-4D57-80B6-9B3A76BC08D2Q34333378-0040E4D0-F056-41B9-B627-620D160175B1Q34484064-A4297E69-E65A-4279-9723-E41A06F24918Q34491695-681EDB70-2958-406D-A776-6C2F68B28EFAQ34525371-8BDD5AD6-B53D-42C9-8F54-FAC10F8EC012Q34714019-ACE58C79-C35B-42C8-B14B-8EF6957DBD4CQ34788148-4A4656F1-9887-403F-B550-5E50DE599030Q35033334-F54E51E9-8B40-4DC3-8437-76D946AC2D29Q35186831-9EC4A18F-323A-4A52-816D-8E596E3CBF53Q35521010-79B21160-F6B5-4CF9-A661-5D848AEBC195Q35589002-703BEC01-5550-45AB-A528-8597F743E8AEQ35940629-DF38463F-A2DF-43DC-8891-F184279EF7D0Q35946937-EEE06FE0-7A0F-4712-A0E1-756105DBC19FQ36228120-931A8356-CB65-4427-B207-8273448BD350Q36345506-17820F68-4004-4CFE-9403-7C2198CE1C42Q36374782-9615CEF0-BCCD-48EC-856D-C9DC4E676790Q37076462-2A84D428-589C-45C5-BC54-DFA1D70B729BQ37248425-46C7768A-246E-495B-994D-CC60F2FE6B2BQ37386300-BC7B094D-30C3-4634-8C2D-A470B57B77DEQ37476759-4A30C9E6-03DF-41C4-8564-EF7FDAEB9C47Q37503262-4DED9B10-B210-4C81-9CF7-12784663CC57Q37737615-0C1D99C6-4800-4122-9454-B89058FDD225Q38215371-172B38A4-297D-4A81-A164-41BC7D454A24Q38731230-51CA3D12-AC8C-41BF-B8B2-E0A5450D37C5Q39493471-AB105962-D983-42E2-985F-5F8D69CCDAA8Q40159743-4E762037-719B-45AB-A4AB-C9C4E1FFDD6CQ40237881-3B76E33B-A503-4C3F-ABBA-2EC16027754DQ41017277-A64EDA96-EA86-4775-9B7B-FF720864E36FQ41908719-F820849E-3306-4042-9089-172B671AD5A7Q41940374-EB358062-461A-447A-B78C-13AD56510760Q44108100-F021E702-D4B6-40C5-BE6D-B7A8E570D71BQ44241192-8CCE0DE6-0E82-410D-B924-5F30292AFE44Q44898942-09A6D05F-A3C4-45C1-8B08-C4FCC35816CEQ46050882-B2692628-286C-430D-9B25-1C10981977CE
P2860
DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
DNA vaccination with genes enc ...... inst lethal challenge in mice.
@ast
DNA vaccination with genes enc ...... inst lethal challenge in mice.
@en
DNA vaccination with genes enc ...... inst lethal challenge in mice.
@nl
type
label
DNA vaccination with genes enc ...... inst lethal challenge in mice.
@ast
DNA vaccination with genes enc ...... inst lethal challenge in mice.
@en
DNA vaccination with genes enc ...... inst lethal challenge in mice.
@nl
prefLabel
DNA vaccination with genes enc ...... inst lethal challenge in mice.
@ast
DNA vaccination with genes enc ...... inst lethal challenge in mice.
@en
DNA vaccination with genes enc ...... inst lethal challenge in mice.
@nl
P2093
P2860
P1476
DNA vaccination with genes enc ...... inst lethal challenge in mice.
@en
P2093
H Verschueren
J De Braekeleer
M Vercammen
P2860
P356
10.1128/IAI.68.1.38-45.2000
P407
P577
2000-01-01T00:00:00Z